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brachytherapy across a range of clinical applications.
 
Figure 1: Measurement vs plan for 2 dwells in each of 5 
catheters from a patient treatment fraction. A subset of all 
measurements is shown. 
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Purpose/Objective: In high dose rate (HDR) brachytherapy of 
the prostate, radioactive dwell positions are delivered by a 
single source inserted via needle catheters into the target 
volume. The rectal mucosa also recieves dose during the 
treatment, which may lead to toxicity effects. An in house 
Matlab programme was utilised to parameterise the rectal 
dose allowing for association with patient reported late 
toxicity. 
Materials and Methods: During treatment of a series of 76 
patients, using ultrasound imaging to localise the anatomy 
and catheter locations. The target volumes and OAR were 
contoured on the ultrasound scan.The anterior rectal mucosal 
wall weas identified by contouring the transrectal ultrasound 
balloon. Source positions and dwell times, along with the 
dose delivered to the patient were computed using the 
Oncentra Prostate treatment planning system (TPS). Data for 
the series of patients were exported from the TPS in DICOM 
format, and a series of parameterisation methods were 
developed in a Matlab environment to assess the rectal dose, 
as shown in figure 1. 
The change in mean LENT SOMA bowel score was calculated 
for each patient for several post-treatment time points over 
a 5 year period, using pre-treatment score as baseline. 
Association between change in mean score and radiation dose 
to the rectum was the examined using spider plots. 
 
Results: Contours of the anterior rectal mucosa were 
voxelised witthin Matlab to allow the dose to the rectal 
mucosa to be analysed directly from the 3D dose grid. Dose 
parameterisations based on dose-surface(DSH) and dose line 
(DLH) histograms were obtained. Parameters for both lateral 
and longitudinal extents of the mucosal dose were produced 
using dose-line histograms in the relevant directions. The 
results of the spider plots indicated 3 patients with the 
largest increases in mean LENT SOMA score (1.7, 1.7, 1.4) 
compared to pre treatment, had recieved higher doses of 
radiation to the rectum (50th percentile dose volumes 438, 
455, 519cGy respectively) than the majority of the patient 
sample. For these 3 the most severe side-effects were seen 
at 6 months. 
Doses ranged from 250 to 588cGy for the remaining 69 
patients. For these patients increases in mean LENT SOMA 
score were 1 or less even though a number of them had 
recieved similar radiation doses to the rectum as the 3 
patients described above. 
Conclusions: We have using Matlab found a number of 
parameters to aid in quantifying the dose to the rectal 
mucosa during HDR proate brachytherapy. the geometry of 
the transrectal probe standardises the rectal anatomy, 
making this treatment technique particularly suited to 
studies of this nature. The results of the analysis showed 
some small associations between dose and late reported 
toxicities; this is to be further studied using prospective data 
and considering other OAR. 
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Purpose/Objective: The objective is the development of a 
fully automatic inverse dose planning optimization tool for 
MRI guided focal HDR prostate brachytherapy with divergent 
needles. The optimizer is tested in a planning study by 
assessing the dose volume parameters. 
Materials and Methods: To develop a fully automatic 
optimizer for a given number of divergent needles (Figure 
1a), the following parameters need to be optimized: (1) the 
position of the center of rotation (2) the angles of the needle 
and (3) the dwell times of the sources. The idea of our 
optimization workflow is to get the most benefit of the linear 
properties of the dwell times regarding the dose. The center 
3rd ESTRO Forum 2015                                                                                                                                         S89 
 
of rotation is exhaustively searched on a grid of 9 different 
points separated by 1cm from the center of the insertion 
area (Figure 1b). For the needle angulation, the method by 
Poulin (2013) for parallel needle positioning was adapted as 
follows: a heuristic is determined by projecting the planning 
target volume (PTV) from the center of rotation into a 
transverse plane and k-means clustering on the indices of the 
latter surface is applied (Figure 1c). The dwell time is 
determined by the resolution of linear equations following a 
similar method described by Goldman (2009) for external 
beam radiotherapy, called Fast Inverse Dose Optimization 
(FIDO). To test this optimizer, a planning study for focal 
prostate brachytherapy was performed. The optimal 
parameters were determined to obtain the desired coverage 
(PTV D95 of 19 Gy) without exceeding the constraints of the 
organs at risk (D10% urethra of 21 Gy, D1 cc bladder and 
rectum of 12 Gy). The dose distribution was calculated on 10 
patients (PTV volumes ranged from 8,5cc to 23,3cc with a 
median of 16,1cc) for 2, 4, 6, 8, 10, 12 and 14 needles by 
using the earlier mentioned constraints as input.  
Results: The average coverage (D95 of PTV) and the dose on 
the organs at risk (D10% urethra, D1cc of bladder and rectum) 
for all 10 patients are depicted in Figure 1d. The quality of 
the dose plan increases with the number of needle insertions. 
On average, a clinical acceptable plan is already reached by 
using four needle insertions. The complete optimization 
workflow took less than 20 minutes on a PC with a 3.10GHz 
Intel® CoreTM i5-2400 processor and 8GB RAM using MATLAB 
R2013a. 
Conclusions: The efficacy of the automated optimization tool 
was demonstrated for focal HDR prostate brachytherapy with 
divergent needles. On average, clinically acceptable plans 
were achieved using 4 needles or more. 
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Purpose/Objective: To determine whether a real-time 3D-
ultrasound (3DUS) imaging improves brachytherapy structure 
delineations for cervical cancer. 
Materials and Methods: MRI, CT, 3DUS (Clarity AutoScan, 
Elekta, Montreal) and CT-3DUS fusion were all used for 
imaging the structures of interest (HR-CTV, cervix, uterus 
and rectum/sigmoid) for cervical cancer brachytherapy 
treatments of 8 consecutive patients. MRI images were 
acquired prior to brachytherapy following EBRT. 3DUS was 
performed simultaneously to the CT planning in the 
treatment room. Fusion between 3DUS and CT was performed 
on the Clarity workstation and the contours were traced 
using the OncentraBrachy planning system (Elekta). 
Coutouring was done by 3 physicians: 2 radiation oncologists 
(RO1 and RO2) and 1 diagnostic radiologist (DR) specialised in 
gynaecology. MRI contours traced by the DR were used as the 
reference set even though the applicators were not yet in 
place. The cervix and the HR-CTV were contoured three 
times by the DR to validate the stability of the reference. 
The absolute volumes and the transverse and longitudinal 
dimensions of the HR-CTV were compared with the reference 
for each imaging modality and physician. 
Results: As expected the CT volumes are larger than MRI 
(Table 1). The MRI contours of the DR and the ROs are 
significativally larger than the intra-observer variability. The 
difference comes from the fact that ROs include treatment 
considerations, which is not the case with the DR. The 3DUS 
volumes are closer to the MRI volumes for each physician, but 
standard deviations are the largest (32% to 42%). CT-3DUS 
fusions keep the benefit of 3DUS alone for volume denifition 
while reducing significantly the variability for each physician. 
The variation in longitudinal dimension of the contours was 
found to have the largest impact on both inter-observers and 
inter-modalities differences in volumes.  
 
Conclusions: Generally, 3DUS allows for contours closer to 
MRI, but offers little information on the OARs. The CT-3DUS 
helps to get that extra information and offers, in axial slices, 
contours closer to MRI in all cases for the ROs compared to 
the CT alone. The learning curve of 3DUS could also explain 
the large standard deviation seen. This technology is 
promising and requires further investigation to determine its 
usefulness in treatment planning.  
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